Literature DB >> 16944010

Severe prolongation of the INR in spur cell anemia of cirrhosis: true-true and related?

Vinay Sundaram1, Abdullah M S Al-Osaimi, Jason J Lewis, Ton Lisman, Stephen H Caldwell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16944010     DOI： 10.1007/s10620-006-8033-8

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  17 in total

Review 1.  Recombinant activated factor VII (rFVIIa) as a hemostatic agent in liver disease: a break from convention in need of controlled trials.

Authors:  Stephen H Caldwell; Charissa Chang; B Gail Macik
Journal:  Hepatology       Date:  2004-03       Impact factor: 17.425

2.  Prothrombin time in liver failure: time, ratio, activity percentage, or international normalized ratio?

Authors:  A Robert; O Chazouillères
Journal:  Hepatology       Date:  1996-12       Impact factor: 17.425

Review 3.  Resolution of spur cell anemia with liver transplantation: a case report and review of the literature.

Authors:  A A Chitale; R K Sterling; A B Post; B J Silver; D C Mulligan; J A Schulak
Journal:  Transplantation       Date:  1998-04-15       Impact factor: 4.939

Review 4.  The international normalized ratio. A guide to understanding and correcting its problems.

Authors:  J Hirsh; L Poller
Journal:  Arch Intern Med       Date:  1994-02-14

5.  Platelet hypersensitivity induced by cholesterol incorporation.

Authors:  S J Shattil; R Anaya-Galindo; J Bennett; R W Colman; R A Cooper
Journal:  J Clin Invest       Date:  1975-03       Impact factor: 14.808

6.  Specific laboratory methodologies achieve higher model for endstage liver disease (MELD) scores for patients listed for liver transplantation.

Authors:  James F Trotter; Brad Brimhall; Russ Arjal; Charles Phillips
Journal:  Liver Transpl       Date:  2004-08       Impact factor: 5.799

7.  Surface morphology of platelets in spur-cell anemia.

Authors:  D C Doll
Journal:  Hum Pathol       Date:  1982-07       Impact factor: 3.466

8.  Red cell lipid abnormalities in acquired acanthocytosis are extended to platelets.

Authors:  C Ulibarrena; A Vecino; J M Cesar
Journal:  Br J Haematol       Date:  1994-07       Impact factor: 6.998

9.  Assessment of the validity of the INR system for patients with liver impairment.

Authors:  M J Kovacs; A Wong; K MacKinnon; K Weir; M Keeney; E Boyle; M Cruickshank
Journal:  Thromb Haemost       Date:  1994-06       Impact factor: 5.249

10.  An analysis of lipoproteins, bile acids, and red cell membranes associated with target cells and spur cells in patients with liver disease.

Authors:  R A Cooper; M Diloy Puray; P Lando; M S Greenverg
Journal:  J Clin Invest       Date:  1972-12       Impact factor: 14.808
View more
  3 in total

1.  Longitudinal assessment of prognostic factors for patients with hepatorenal syndrome in a tertiary center.

Authors:  Ya-Wen Yang; Che-Hsiung Wu; Rey-Heng Hu; Ming-Chin Ho; Meng-Kun Tsai; Yao-Ming Wu; Po-Huang Lee
Journal:  Hepatol Int       Date:  2010-05-19       Impact factor: 6.047

Review 2.  Spur cell anemia related to alcoholic liver cirrhosis managed without liver transplantation: a case report and literature review.

Authors:  Takao Miwa; Yuichiro Hatano; Takahiro Kochi; Masashi Aiba; Katsuhisa Toda; Hideko Goto; Noriaki Nakamura; Naoki Katsumura; Kenji Imai; Masahito Shimizu
Journal:  Clin J Gastroenterol       Date:  2020-05-29

3.  The Diagnosis Is in the Smear: A Case and Review of Spur Cell Anemia in Cirrhosis.

Authors:  Gabriella A Raffa; Diana M Byrnes; John J Byrnes
Journal:  Case Rep Hematol       Date:  2021-03-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.